Category: News WellSyndicate content

Content tagged to appear in the middle column of the home page

DAPT funk: Study raises questions about Boston Scientific's Synergy stent

November 26, 2014 by Val Kennedy

Researchers for the massive DAPT study find that drug-eluting stents may be safer than bare-metal stents, calling into question the value of Boston Scientific's next-gen Synergy stent.

DAPT funk: Study raises questions about Boston Scientific's Synergy stent

Researchers for the massive Dual Anti-platelet Therapy Study found that patients receiving drug-eluting stents had a lower rate of stent thrombosis and other major cardiovascular events than those treated with bare-metal stents, undermining the common perception that bare-metal stents are safer.

HCA hospitals halt use of uterine fibroid surgical tool

November 25, 2014 by MassDevice

HCA Holdings halts the use of laparoscopic power morcellators in uterine fibroid surgeries in all 278 of its facilities, after the FDA raises the warning level on the cancer risk associated with the devices.

HCA hospitals halt use of uterine fibroid surgical tool

(Reuters) — HCA Holdings (NYSE:HCA), the largest for-profit U.S. hospital operator, said a procedure for removing uterine fibroids that's been linked to the spread of cancer will no longer be performed at its facilities.

Vascular Solutions wins FDA nod for Gel-Block embolization foam

November 25, 2014 by Mark Hollmer

Vascular Solutions says the FDA granted 510(k) clearance for its Gel-Block embolization foam.

Vascular Solutions wins FDA nod for embolization foam

MassDevice.com +3 | The top 3 medtech stories for November 25, 2014

November 25, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Medtronic expects to free up to $4B after IRS beef is settled

November 25, 2014 by Brad Perriello

Medtronic says it expects to repatriate as much as $4 billion in cash after it resolves a dispute with the IRS involving its Puerto Rico subsidiary.

Medtronic expects to free up to $4B after IRS beef is settled

Medtronic (NYSE:MDT) said today that it expects to land a substantial windfall once it resolves a dispute with the IRS over the next "couple of years."

Plaintiffs in Bard's pelvic mesh MDL want cases tried together

November 25, 2014 by Brad Perriello

The plaintiffs in 185 lawsuits filed against C.R. Bard over its Avaulta pelvic mesh as part of a multi-district litigation want their cases tried together.

Plaintiffs in Bard's pelvic mesh MDL want cases tried together
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp